Literature DB >> 4851052

Clinical significance of generic inequivalence of three different pharmaceutical preparations of phenytoin.

L Lund.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4851052     DOI: 10.1007/bf00561325

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  9 in total

1.  Studies on 5, 5'-diphenylhydantoin (dilantin) in animals and man.

Authors:  W A DILL; A J GLAZKO; A KAZENKO; L M WOLF
Journal:  J Pharmacol Exp Ther       Date:  1956-11       Impact factor: 4.030

2.  Physiological Availability of Dicumarol.

Authors:  E Lozinski
Journal:  Can Med Assoc J       Date:  1960-07-23       Impact factor: 8.262

3.  Pharmacokinetics of single and multiple doses of phenytoin in man.

Authors:  L Lund; G Alvan; A Berlin; B Alexanderson
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

4.  The generic inequivalence of drugs.

Authors:  A B Varley
Journal:  JAMA       Date:  1968-11-18       Impact factor: 56.272

5.  Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.

Authors:  A Berlin; S Agurell; O Borgå; L Lund; F Sjöqvist
Journal:  Scand J Clin Lab Invest       Date:  1972-05       Impact factor: 1.713

6.  An evaluation of the absorption characteristics of different chloramphenicol preparations in normal human subjects.

Authors:  A J Glazko; A W Kinkel; W C Alegnani; E L Holmes
Journal:  Clin Pharmacol Ther       Date:  1968 Jul-Aug       Impact factor: 6.875

7.  "Dilantin" overdosage.

Authors:  M J Eadie; J M Sutherland; J H Tyrer
Journal:  Med J Aust       Date:  1968-09-21       Impact factor: 7.738

8.  "Dilantin" overdosage.

Authors:  L Rail
Journal:  Med J Aust       Date:  1968-08-17       Impact factor: 7.738

9.  Outbreak of anticonvulsant intoxication in an Australian city.

Authors:  J H Tyrer; M J Eadie; J M Sutherland; W D Hooper
Journal:  Br Med J       Date:  1970-10-31
  9 in total
  15 in total

Review 1.  Theoretical predictions of drug absorption in drug discovery and development.

Authors:  Patric Stenberg; Christel A S Bergström; Kristina Luthman; Per Artursson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Bioavailability of phenytoin. A comparison of two preparations.

Authors:  M J Stewart; B R Ballinger; E J Devlin; A Y Miller; A C Ramsay
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

3.  The pharmacokinetics of acetanilide and of diphenylhydantoin sodium.

Authors:  J L Cunningham; M F Bullen; D A Evans
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

4.  A comparison between microcrystalline and conventional phenytoin preparations: relative bioavailability and steady-state plasma concentrations.

Authors:  L O Boréus; A Nergårdh; M Ehrnebo; K Theorell
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

5.  Drug-related problems causing admission to a medical clinic.

Authors:  U Bergman; B E Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Influence of food on the absorption of phenytoin in man.

Authors:  A Melander; G Brante; O Johansson; T Lindberg; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

7.  Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing.

Authors:  P Bielmann; T Levac
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

8.  Bioavailability and dissolution of proprietary and generic formulations of phenytoin.

Authors:  I Soryal; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

9.  Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

Authors:  A Richens
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

10.  Bioavailability of three phenytoin preparations in healthy subjects and in epileptics.

Authors:  B Rambeck; H E Boenigk; E Stenzel
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.